Biocartis at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Biocartis brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 623. Its session covers decentralized precision testing in real world settings, with gene signatures and artificial intelligence in the mix. The Idylla platform returns molecular biomarker results inside a laboratory's own walls within hours.
| Organization | AMP 2026 Attendance |
|---|---|
Biocartis Mechelen, Belgium | |
Idylla platform delivering in-house molecular biomarker results in about three hours, with diagnostic tests and research assays across several cancers. | Booth Exhibiting at Booth 623 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Decentralized precision testing: AI, Gene Signatures, and Rapid Biomarker Testing in real world settings Rapid biomarker testing and AI tools deployed in community health systems alongside academic cancer centres. |
Instantly find 20 buyers from Biocartis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction